ConductScience.org, home

Paper41599232

Cellular Allies Against Glioblastoma: Therapeutic Potential of Macrophages and Mesenchymal Stromal Cells.

Cesca BA and 2 others. Pharmaceutics, 2026. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Cellular Allies Against Glioblastoma: Therapeutic Potential of Macrophages and Mesenchymal Stromal Cells. Papers, record 41599232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41599232

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cellular Allies Against Glioblastoma: Therapeutic Potential of Macrophages and Mesenchymal Stromal Cells.
PubMed
Journal
Pharmaceutics
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2026-01-31
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cesca BABruno Agustínhttps://orcid.org/0009-0005-4936-3595
2Pellicer San Martin KKalihttps://orcid.org/0009-0007-5940-7824
3Ibarra LELuis Exequielhttps://orcid.org/0000-0002-6077-7992

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
PICT 2020/00051Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la InnovaciónPubMed
2024National University of Río CuartoPubMed

Source PubMed

Download CSV of grants

References260

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11701343Adoptive transfer of tumor cytotoxic macrophages generated in vitro from circulating blood monocytes: a new approach to cancer immunotherapy.Cancer Res1990https://conductscience.org/library/papers/1701343PubMed
238031182The effect of TLR3 priming conditions on MSC immunosuppressive properties.Stem Cell Res Ther2023https://conductscience.org/library/papers/38031182PubMed
333855018Elucidating the Biomechanics of Leukocyte Transendothelial Migration by Quantitative Imaging.Front Cell Dev Biol2021https://conductscience.org/library/papers/33855018PubMed
429273086Immunoprivileged no more: measuring the immunogenicity of allogeneic adult mesenchymal stem cells.Stem Cell Res Ther2017https://conductscience.org/library/papers/29273086PubMed
525326491RAGE expression in tumor-associated macrophages promotes angiogenesis in glioma.Cancer Res2014https://conductscience.org/library/papers/25326491PubMed
635921473Intracavity generation of glioma stem cell-specific CAR macrophages primes locoregional immunity for postoperative glioblastoma therapy.Sci Transl Med2022https://conductscience.org/library/papers/35921473PubMed
731629410Tumor-associated macrophages: an accomplice in solid tumor progression.J Biomed Sci2019https://conductscience.org/library/papers/31629410PubMed
837190507Exploring Monocytes-Macrophages in Immune Microenvironment of Glioblastoma for the Design of Novel Therapeutic Strategies.Brain Sci2023https://conductscience.org/library/papers/37190507PubMed
938474286Glioblastoma: An Update in Pathology, Molecular Mechanisms and Biomarkers.Int J Mol Sci2024https://conductscience.org/library/papers/38474286PubMed
1031649208Differentiation of Human Mesenchymal Stem Cells towards Neuronal Lineage: Clinical Trials in Nervous System Disorders.Biomol Ther (Seoul)2020https://conductscience.org/library/papers/31649208PubMed
1129422647Vascular niche IL-6 induces alternative macrophage activation in glioblastoma through HIF-2α.Nat Commun2018https://conductscience.org/library/papers/29422647PubMed
1231728942Delivery across the blood-brain barrier: nanomedicine for glioblastoma multiforme.Drug Deliv Transl Res2020https://conductscience.org/library/papers/31728942PubMed
1337474525Multi-omics analysis of human mesenchymal stem cells shows cell aging that alters immunomodulatory activity through the downregulation of PD-L1.Nat Commun2023https://conductscience.org/library/papers/37474525PubMed
1437470820Scalable manufacturing of gene-modified human mesenchymal stromal cells with microcarriers in spinner flasks.Appl Microbiol Biotechnol2023https://conductscience.org/library/papers/37470820PubMed
1532943658Downregulation of the CCL2/CCR2 and CXCL10/CXCR3 axes contributes to antitumor effects in a mouse model of malignant glioma.Sci Rep2020https://conductscience.org/library/papers/32943658PubMed
1634209703Macrophage Polarization States in the Tumor Microenvironment.Int J Mol Sci2021https://conductscience.org/library/papers/34209703PubMed
1738852095Allogeneic stem cells engineered to release interferon β and scFv-PD1 target glioblastoma and alter the tumor microenvironment.Cytotherapy2024https://conductscience.org/library/papers/38852095PubMed
1830034643Molecular subtypes and differentiation programmes of glioma stem cells as determinants of extracellular vesicle profiles and endothelial cell-stimulating activities.J Extracell Vesicles2018https://conductscience.org/library/papers/30034643PubMed
1933368262Reverted effect of mesenchymal stem cells in glioblastoma treated with agathisflavone and its selective antitumoral effect on cell viability, migration, and differentiation via STAT3.J Cell Physiol2021https://conductscience.org/library/papers/33368262PubMed
2030393022Human placenta-derived mesenchymal stem cells ameliorate GVHD by modulating Th17/Tr1 balance via expression of PD-L2.Life Sci2018https://conductscience.org/library/papers/30393022PubMed

See all 260 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42882426Stromal Remodeling of the Cytokine Secretome Reveals a Chemokine Core Across Breast Cancer and Glioma 3D Cell Culture Models.Cells2026https://conductscience.org/library/papers/42882426PubMed
42840645Extracellular vesicles as biomimetic platforms for photo-assisted cancer therapy: evolution from synthetic nanocarriers to engineered therapeutic systems.Front Oncol2026https://conductscience.org/library/papers/42840645PubMed
42797367Mechanism-Driven Design of Metal-Phenolic Networks: From Precision Assembly to Multidimensional Synergistic Therapy for Brain Diseases.Pharmaceutics2026https://conductscience.org/library/papers/42797367PubMed
42338608Rearming mesenchymal stem cells with engineering strategies to combat cancer.Front Immunol2026https://conductscience.org/library/papers/42338608PubMed
42192855New Advances in the Development of New Drugs and Treatment Targets for Brain Cancers (2nd Edition).Brain Sci2026https://conductscience.org/library/papers/42192855PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41599232

GET https://conductscience.org/api/papers/v1/41599232/references?page=2